EYENOVIA INC (EYEN) Stock Price, Quote, News and Overview
NASDAQ:EYEN - Nasdaq - US30234E2037 - Common Stock - Currency: USD
EYEN Quote, Performance and Key Statistics
1.17
+0.02 (+1.74%)
The current stock price of EYEN is 1.17 USD. In the past month the price increased by 5.41%. In the past year, price decreased by -98.55%.
EYEN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 59.86 | 780.78B | ||
| JNJ | JOHNSON & JOHNSON | 15.53 | 376.23B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 20.01 | 307.32B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.75 | 225.73B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 19.47 | 224.59B | ||
| MRK | MERCK & CO. INC. | 10.68 | 209.31B | ||
| PFE | PFIZER INC | 7.54 | 137.25B | ||
| SNY | SANOFI-ADR | 14.36 | 135.72B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.89 | 102.91B | ||
| GSK | GSK PLC-SPON ADR | 7.09 | 79.05B | ||
| ZTS | ZOETIS INC | 26.59 | 70.23B | ||
| HLN | HALEON PLC-ADR | 21.84 | 48.28B |
Related stock screener links
About EYEN
Company Profile
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company is headquartered in New York City, New York and currently employs 13 full-time employees. The company went IPO on 2018-01-25. The company is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.
Company Info
EYENOVIA INC
295 Madison Ave Ste 2400
New York City NEW YORK 10017 US
CEO: Tsontcho Ianchulev
Employees: 57
Company Website: https://eyenovia.com/
Investor Relations: http://ir.eyenovia.com/
Phone: 18137669539
EYENOVIA INC / EYEN FAQ
What is the stock price of EYENOVIA INC today?
The current stock price of EYEN is 1.17 USD. The price increased by 1.74% in the last trading session.
What is the ticker symbol for EYENOVIA INC stock?
The exchange symbol of EYENOVIA INC is EYEN and it is listed on the Nasdaq exchange.
On which exchange is EYEN stock listed?
EYEN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for EYENOVIA INC stock?
8 analysts have analysed EYEN and the average price target is 163.2 USD. This implies a price increase of 13848.72% is expected in the next year compared to the current price of 1.17. Check the EYENOVIA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EYENOVIA INC worth?
EYENOVIA INC (EYEN) has a market capitalization of 3.31M USD. This makes EYEN a Nano Cap stock.
How many employees does EYENOVIA INC have?
EYENOVIA INC (EYEN) currently has 57 employees.
What are the support and resistance levels for EYENOVIA INC (EYEN) stock?
EYENOVIA INC (EYEN) has a support level at 1.09 and a resistance level at 1.36. Check the full technical report for a detailed analysis of EYEN support and resistance levels.
Is EYENOVIA INC (EYEN) expected to grow?
The Revenue of EYENOVIA INC (EYEN) is expected to grow by 400.98% in the next year. Check the estimates tab for more information on the EYEN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EYENOVIA INC (EYEN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EYEN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EYEN, evaluating the profitability, health, valuation and growth aspects
- EYENOVIA INC (EYEN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EYENOVIA INC (EYEN) Sales and EPS estimates to see what analysts future expectations are.
- EYENOVIA INC (EYEN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EYENOVIA INC (EYEN) Insider and Institutional Ownership to learn about the owners and their transactions.
- EYENOVIA INC (EYEN) Stock Chart to make your own analysis
- EYENOVIA INC (EYEN) Latest news and press-releases to stay up to date.
Does EYENOVIA INC (EYEN) stock pay dividends?
EYEN does not pay a dividend.
When does EYENOVIA INC (EYEN) report earnings?
EYENOVIA INC (EYEN) will report earnings on 2025-05-13, after the market close.
What is the Price/Earnings (PE) ratio of EYENOVIA INC (EYEN)?
EYENOVIA INC (EYEN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-32.76).
What is the Short Interest ratio of EYENOVIA INC (EYEN) stock?
The outstanding short interest for EYENOVIA INC (EYEN) is 2.96% of its float. Check the ownership tab for more information on the EYEN short interest.
EYEN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to EYEN. When comparing the yearly performance of all stocks, EYEN is a bad performer in the overall market: 98.84% of all stocks are doing better.
EYEN Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to EYEN. EYEN has a bad profitability rating. Also its financial health evaluation is rather negative.
EYEN Financial Highlights
Over the last trailing twelve months EYEN reported a non-GAAP Earnings per Share(EPS) of -32.76. The EPS decreased by -4789.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1358.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
EYEN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 48% to EYEN. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -3.37% and a revenue growth 400.98% for EYEN